News | Radiation Therapy | August 04, 2016

Latest version of software enables gold standard accuracy combined with speed and performance 

treatment planning

Elekta showcased the latest version of its treatment planning software, Monaco version 5.11 at the 58th American Association of Physicists in Medicine (AAPM) meeting in July. Monaco 5.11, which enables users to attain calculation speeds up to four times faster than previous versions, is cloud capable and is currently installed at several customer sites. Monaco continues to utilize multicriteria optimization and Monte Carlo dose calculations for high-quality dependable treatment planning results.

Monaco templates further increase efficiency by allowing users to easily import and export treatment plans, facilitating best practice sharing across departments and organizations. The ability to create multiple prescription plans simultaneously reduces overall planning time as well. Improved data sharing creates opportunities to optimize individual treatment plans.

“Elekta’s Versa HD linear accelerator and Monaco treatment planning system combine unrivalled dose delivery and intelligent dose planning,” said Elekta’s David Mellenberg, Ph.D., DABR. “The efficiency and precision of Versa HD are enhanced when combined with the Multicriteria Optimization and Gold Standard Monte Carlo calculations in Monaco 5.11. Together, they make dynamic and stereotactic techniques not only possible, but routine practice.”

“We successfully installed Monaco 5.11 at our large center, which treats more than 250 patients daily across two campuses,” said Miller MacPherson, Ph.D., FCCPM, head of physics at The Ottawa Hospital. “VMAT planning is fast and our physics team was able to generate really solid beam models. As a result, we are seeing improvements in IMRT and VMAT QA. We are very pleased with the support we received from Elekta and proud of our physics and planning teams’ accomplishments and hard work transitioning from XiO® to Monaco.”

In addition to Monaco 5.11, the following solutions weree highlighted: The latest version of Mosaiq, which provides numerous workflow enhancements including IQ Scripts Plan of the Day, ePrescribing for controlled substances and many other time saving features; Leksell Gamma Knife Icon, a brain radiosurgery system offering novel technology including true stereotactic CBCT and online adaptive planning capability; iView Dose software, Elekta’s EPID-based in vivo dosimetry solution, which offers an essential safety check during radiation therap ; AQUA, a quality management system which offers a full suite of workflow-oriented machine QA tasks; and Mosaiq Oncology Analytics, which aggregates data to bring clinical, operational and financial insights to the surface.

For more information: www.elekta.com/AAPM


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now